[HTML][HTML] Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
Z Yan, Y Lijuan, W Yinhang, J Yin, X Jiamin… - World Journal of …, 2022 - Springer
Background Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
[HTML][HTML] Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
Z Yan, Y Lijuan, W Yinhang, J Yin… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Background Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
[HTML][HTML] Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
Z Yan, Y Lijuan, W Yinhang, J Yin… - World Journal of …, 2022 - wjso.biomedcentral.com
Liver cancer is one of the most common malignant tumors in the world. T cell-mediated
antitumor immune response is the basis of liver cancer immunotherapy. To screen and …
antitumor immune response is the basis of liver cancer immunotherapy. To screen and …
Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer.
Z Yan, Y Lijuan, W Yinhang, J Yin, X Jiamin… - World Journal of …, 2022 - go.gale.com
Background Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer.
Z Yan, Y Lijuan, W Yinhang, J Yin… - World Journal of …, 2022 - search.ebscohost.com
Background: Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
Y Zhang, Y Lijuan, W Yinhang, J Yin… - World Journal of …, 2022 - search.proquest.com
Background Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer.
Z Yan, Y Lijuan, W Yinhang, J Yin, X Jiamin… - World Journal of …, 2022 - europepmc.org
Background Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
Z Yan, Y Lijuan, W Yinhang, J Yin… - World journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
[PDF][PDF] Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer
Z Yan, Y Lijuan, W Yinhang, J Yin, X Jiamin, W Wei… - 2021 - wjso.biomedcentral.com
Background: Liver cancer is one of the most common malignant tumors in the world. T cell-
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …
mediated antitumor immune response is the basis of liver cancer immunotherapy. Objective …